NCT03180437View on ClinicalTrials.gov

Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

June 15, 2017

Primary Completion Date

June 15, 2018

Study Completion Date

June 15, 2019

Conditions
Pancreatic Cancer
Interventions
PROCEDURE

IRE surgery

IRE surgery will be used in local tumor

BIOLOGICAL

IRE plus γδ T cells

Combination IRE surgery and γδ T cell will be used in Pancreatic Cancer

Trial Locations (1)

510665

Biotherapy center in Fuda cancer hospital, Guangzhou

All Listed Sponsors
collaborator

Jinan University Guangzhou

OTHER

lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT03180437 - Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer | Biotech Hunter | Biotech Hunter